Showing results (121-130 of 127) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Atherosclerosis|March 1, 2011
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular eventsT Sehestedt, S Lyngbæk, J Eugen-Olsen, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2011
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and menS B Haugaard, O Andersen, T W Hansen, et al.Journal of Human Hypertension|March 27, 2015
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)S Theilade, B Claggett, T W Hansen, et al.Journal of Diabetes and Its Complications|July 30, 2016
High osteoprotegerin is associated with development of foot ulcer in type 1 diabetesEmilie H Zobel, Bernt J von Scholten, Maria Lajer, et al.Anesthesia and Analgesia|January 1, 1990
Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanilP L Bailey, J B Streisand, K A East, et al.Journal of Internal Medicine|June 22, 2010
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJ Eugen-Olsen, O Andersen, A Linneberg, et al.Journal of Human Hypertension|January 17, 2014
Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populationsT W Hansen, L Thijs, Y Li, et al.Pageof 13